Cutera, Inc. (NASDAQ:CUTR) is scheduled to be issuing its quarterly earnings data after the market closes on Monday, November 6th. Analysts expect the company to announce earnings of $0.08 per share for the quarter.

Cutera (NASDAQ:CUTR) last released its earnings results on Monday, August 7th. The medical device company reported $0.13 EPS for the quarter, topping analysts’ consensus estimates of $0.03 by $0.10. Cutera had a return on equity of 11.64% and a net margin of 5.07%. The firm had revenue of $36.40 million for the quarter, compared to analysts’ expectations of $32.08 million. During the same period in the prior year, the firm posted $0.07 earnings per share. The company’s quarterly revenue was up 32.4% on a year-over-year basis. On average, analysts expect Cutera to post $0.55 EPS for the current fiscal year and $0.85 EPS for the next fiscal year.

Shares of Cutera, Inc. (NASDAQ CUTR) opened at 39.00 on Monday. Cutera, Inc. has a 1-year low of $12.45 and a 1-year high of $44.40. The stock has a market capitalization of $546.20 million, a PE ratio of 83.87 and a beta of 0.53. The stock has a 50 day moving average price of $40.43 and a 200-day moving average price of $29.64.

Cutera declared that its board has approved a stock buyback program on Monday, August 7th that authorizes the company to repurchase $25.00 million in shares. This repurchase authorization authorizes the medical device company to repurchase up to 6.8% of its shares through open market purchases. Shares repurchase programs are often an indication that the company’s management believes its stock is undervalued.

Several research analysts have recently commented on the company. Roth Capital boosted their price target on Cutera from $32.00 to $39.00 and gave the stock a “buy” rating in a research report on Tuesday, August 8th. Zacks Investment Research lowered Cutera from a “buy” rating to a “hold” rating in a research report on Tuesday, October 10th. Maxim Group lowered Cutera from a “buy” rating to a “hold” rating in a research report on Thursday, September 14th. BidaskClub raised Cutera from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, July 12th. Finally, Sidoti reissued a “buy” rating and issued a $32.00 price target (up from $30.00) on shares of Cutera in a research report on Friday, July 7th. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $37.33.

ILLEGAL ACTIVITY WARNING: This report was first reported by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another site, it was stolen and reposted in violation of international copyright & trademark law. The original version of this report can be read at

In related news, Director David B. Apfelberg sold 1,000 shares of the company’s stock in a transaction dated Wednesday, October 18th. The stock was sold at an average price of $39.90, for a total transaction of $39,900.00. Following the transaction, the director now directly owns 10,259 shares of the company’s stock, valued at approximately $409,334.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Ronald J. Santilli sold 1,068 shares of the company’s stock in a transaction dated Tuesday, August 15th. The shares were sold at an average price of $33.20, for a total value of $35,457.60. Following the transaction, the executive vice president now directly owns 87,253 shares in the company, valued at $2,896,799.60. The disclosure for this sale can be found here. Over the last three months, insiders sold 61,809 shares of company stock valued at $2,182,510. Corporate insiders own 3.30% of the company’s stock.

About Cutera

Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.

Earnings History for Cutera (NASDAQ:CUTR)

Receive News & Ratings for Cutera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera Inc. and related companies with's FREE daily email newsletter.